Snapshot from Jul 07, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / Elanco

United States — Food and Drug Administration & Elanco

1 shared events · Importance 3 · Last updated Jun 12, 2026

Importance
3
Shared Events
1
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (1)
53
Business
Zoetis Securities Fraud Class Actions
United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs related to Zoetis' Bedinvetmab, contributing to its weakening adoption.
Elanco: Elanco is a competitor to Zoetis, with its products Credelio Quattro and Ilunocitinib gaining market share from Zoetis' key companion animal products.
May 18, 2026 · 251 articles
NEWSDESK
Explore this relationship live

Track how United States — Food and Drug Administration and Elanco interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.